Literature DB >> 11368412

Expression of glyoxalase I and II in normal and breast cancer tissues.

A Rulli1, L Carli, R Romani, T Baroni, E Giovannini, G Rosi, V Talesa.   

Abstract

The present work aimed to study the activities of glyoxalase system enzymes, glyoxalase I (G I) and glyoxalase II (G II), as well as the expression of their genes in human breast carcinoma. Samples of tumoral tissue and normal counterparts were drawn from several patients during surgery. They served either for preparing extracts to be used in enzyme activity evaluations or for RNA extraction and subsequent northern blot analysis. A far higher activity level of G I and G II occurs in the tumor compared with pair-matched normal tissue, as shown by both spectrophotometrical assay and electrophoretic pattern. Such increased activities of G I and G II likely result from an enhanced enzyme synthesis as a consequence of increased expression of the respective genes in the tumoral tissue, as evidenced by northern blot. The present findings confirm a key-role of glyoxalase system to detoxify cytotoxic methylglyoxal and modulate S-D-lactoylglutathione levels in tumor cells. Moreover, they suggest a possible employment of GI inhibitors as anti-cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368412     DOI: 10.1023/a:1010632919129

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  39 in total

1.  Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry.

Authors:  Timothy Synold; Bixin Xi; Gerald E Wuenschell; Daniel Tamae; James L Figarola; Samuel Rahbar; John Termini
Journal:  Chem Res Toxicol       Date:  2008-11       Impact factor: 3.739

2.  Phenolic constituents from stem bark of Erythrina poeppigiana and their inhibitory activity on human glyoxalase I.

Authors:  Kiyomi Hikita; Hitoshi Tanaka; Tomiyasu Murata; Kuniki Kato; Miyuki Hirata; Tatsuko Sakai; Norio Kaneda
Journal:  J Nat Med       Date:  2014-04-23       Impact factor: 2.343

3.  New Arabidopsis thaliana cytochrome c partners: a look into the elusive role of cytochrome c in programmed cell death in plants.

Authors:  Jonathan Martínez-Fábregas; Irene Díaz-Moreno; Katiuska González-Arzola; Simon Janocha; José A Navarro; Manuel Hervás; Rita Bernhardt; Antonio Díaz-Quintana; Miguel Á De la Rosa
Journal:  Mol Cell Proteomics       Date:  2013-09-09       Impact factor: 5.911

4.  Glyoxalase I activity and immunoreactivity in the aging human lens.

Authors:  Maneesh Mailankot; Smitha Padmanabha; NagaRekha Pasupuleti; Denice Major; Scott Howell; Ram H Nagaraj
Journal:  Biogerontology       Date:  2009-12       Impact factor: 4.277

5.  Tumour necrosis factor induces phosphorylation primarily of the nitric-oxide-responsive form of glyoxalase I.

Authors:  Virginie de Hemptinne; Dieter Rondas; Joël Vandekerckhove; Katia Vancompernolle
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

6.  The metal ion requirements of Arabidopsis thaliana Glx2-2 for catalytic activity.

Authors:  Pattraranee Limphong; Ross M McKinney; Nicole E Adams; Christopher A Makaroff; Brian Bennett; Michael W Crowder
Journal:  J Biol Inorg Chem       Date:  2009-10-16       Impact factor: 3.358

7.  Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2.

Authors:  Yi Guo; Yuning Zhang; Xunjun Yang; Panpan Lu; Xijuan Yan; Fanglan Xiao; Huaibin Zhou; Chaowei Wen; Mengru Shi; Jianxin Lu; Qing H Meng
Journal:  Cancer Biol Ther       Date:  2015-11-30       Impact factor: 4.742

8.  Arabidopsis thaliana GLX2-1 contains a dinuclear metal binding site, but is not a glyoxalase 2.

Authors:  Pattraranee Limphong; Michael W Crowder; Brian Bennett; Christopher A Makaroff
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

9.  The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced proteomic changes in the mouse striatum.

Authors:  Seung-Tae Kim; Woongjoon Moon; Younbyoung Chae; Youn Jung Kim; Hyejung Lee; Hi-Joon Park
Journal:  J Physiol Sci       Date:  2009-09-18       Impact factor: 2.781

10.  Troglitazone reverses the multiple drug resistance phenotype in cancer cells.

Authors:  Gerald F Davies; Bernhard H J Juurlink; Troy A A Harkness
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.